Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
163,926,065
-
Total 13F shares
-
24,223,914
-
Share change
-
+24,223,914
-
Total reported value
-
$487,607,000
-
Price per share
-
$20.19
-
Number of holders
-
48
-
Value change
-
+$487,606,790
-
Number of buys
-
48
Institutional Holders of Dyne Therapeutics, Inc. - COMMON STOCK (DYN) as of Q3 2020
As of 30 Sep 2020,
Dyne Therapeutics, Inc. - COMMON STOCK (DYN) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,223,914 shares.
The largest 10 holders included
MPM ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, Logos Global Management LP, JANUS HENDERSON GROUP PLC, HILLHOUSE CAPITAL ADVISORS, LTD., PRICE T ROWE ASSOCIATES INC /MD/, and NORGES BANK.
This page lists
48
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.